Alice in Wonderland Syndrome: An Update of Present Data with a Special View to Body Position, Traumatic and Genetic Aspects
Journal Title: Journal of Regenerative Biology and Medicine - Year 2020, Vol 2, Issue 6
Abstract
Alice in Wonderland Syndrome (AIWS) was named after the description of Lewis Carroll in his novel. In 1955, John Todd, a psychiatrist described this entity for the first time and results in a distortion of perception. Todd described it as „Alice's Adventures in Wonderland“ by Lewis Carroll. The author Carroll suffered from severe migraine attacks. Alice in Wonderland Syndrome is a disorienting condition of seizures affecting visual perception. AIWS is a neurological form of seizures influencing the brain, thereby causing a disturbed perception. Patients describe visual, auditory, and tactile hallucinations and disturbed perceptions. The causes of AIWS are still not known exactly. Cases of migraine, brain tumors, depression episodes, epilepsy, delirium, psychoactive drugs, ischemic stroke, depressive disorders, and EBV, mycoplasma, and malaria infections are correlating with AIWS like seizures. Often no EEG correlate is found. Neuroimaging studies reveal disturbances of brain regions including the temporoparietal junction, the temporal and occipital lobe as typical localization of the visual pathway. A decrease of perfusion of the visual pathways could induce these disturbances, especially in the temporal lobe in patients with AIWS. Other theories suggest distorted body illusions stem from the parietal lobe. The concrete origin of this mysterious syndrome is to date not clearly defined.
Authors and Affiliations
Stefan Bittmann1*, Elisabeth Luchter2, Anne Weissenstein3, Lara Bittmann4, Elena Moschüring-Alieva5 and Gloria Villalon6
Keywords
Related Articles
- EP ID EP707352
- DOI https://doi.org/10.37191/Mapsci-2582-385X-2(6)-049
- Views 58
- Downloads 0
First-level Neurocognitive Screening Tests and their Application
In June 2021, the Food and Drug Administration approved Aducanumab for the treatment of Alzheimer’s disease – the most common cause of dementia worldwide [1]. This drug is a monoclonal antibody that would be cause amylo...
Long Time Coming - Medihoney™ is also Gaining Ground in Pediatrics
The relevance of inexpensive but at the same time highly effective medicines is steadily increasing in today's society. It is, therefore, no wonder that medicinal honey, whose antibacterial effect was already known in An...
Virtual Reality (VR) in Pediatrics: Innovative Perspectives with Special Reference to Clinical Applications and Pediatric Rehabilitation
Virtual reality (VR) is the term used to describe representation and perception in a computer-generated, virtual environment. The term was coined by author Damien Broderick in his 1982 novel “The Judas Mandala". The term...
Kawasaki Syndrome: A Special View to New Entities Like MIS-C, PIMS and Kawasaki-Like Features In Covid-19 Disease with Recommendation of Classification
Kawasaki syndrome or mucocutaneous lymph node syndrome (MCLS) is an acute, febrile, systemic illness characterized by inflammation (necrotizing vasculitis) of the small and medium-sized arteries. In addition, systemic in...
Neuropilin-1 in Transmission Process of COVID-19
What we know well so far is that SAS-CoV-2 docks to the angiotensin-2 receptor in the lungs. Recent publications by two research teams from Munich (Germany) and Bristol (Great Britain) shed light on the puzzling role of...